OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
Year | Revenue |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹52 Cr |
Mar2020 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 27.93 | |
Mar2023 | ₹31 Cr | -48.80 | |
Mar2022 | ₹61 Cr | 16.33 | |
Mar2021 | ₹52 Cr | 279.32 | |
Mar2020 | ₹14 Cr | - |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹402.4 Cr | 13.2% | 29.5% | 177.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,868.0 Cr | 0.3% | -5.5% | 14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,010.0 Cr | 0.3% | 7.9% | 53.5% | Stock Analytics | |
CIPLA | ₹120,318.0 Cr | 1.7% | -1.3% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,644.0 Cr | 3.1% | 11.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,406.0 Cr | -1% | -4.4% | 16.3% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 13.2% |
29.5% |
177.7% |
SENSEX | -0.2% |
1% |
10.2% |
You may also like the below Video Courses